在心脏再同步治疗中,左束支部区域节奏与双管节律节奏:系统审查和元分析
Nomesh Kumar1, Akash Kumar2, Shanzay Akhtar3
1Department of Medicine, OSF Saint Francis Medical Center, Peoria, Illinois, USA.
Critical pathways in cardiology
|January 14, 2026
概括
左捆支部区域节奏 (LBBAP) 与双心室节奏 (BiVP) 相比,可显著降低心脏再同步治疗 (CRT) 患者的死亡率和住院病例. 此外,LBBAP还可以改善心脏功能,缩短手术时间.
科学领域:
- 心脏病学 心脏病学
- 电力生理学 电力生理学
- 医疗技术 医疗技术 医学技术
背景情况:
- 左捆支部区域节奏 (LBBAP) 是心脏再同步治疗 (CRT) 的双心脏节奏 (BiVP) 的替代方案.
- LBBAP的生理向提供了与BiVP相比的潜在优势.
研究的目的:
- 在CRT患者中系统地审查和比较LBBAP与BiVP的临床和程序结果.
- 评估LBBAP对死亡率,住院和心脏功能的影响.
主要方法:
- 进行了主要数据库 (PubMed,Cochrane Central,Embase) 的系统搜索.
- 包括的研究是随机和观察性,在CRT中比较LBBAP和BiVP.
- 分析使用逆变量随机效应模型来评估死亡率,LVEF和QRS持续时间等结果.
主要成果:
- 与BiVP相比,LBBAP显著降低了全因死亡率 (9.9%与13.9%) 和与HF相关的住院治疗.
- LBBAP导致LVEF (4.71%) 和QRS持续时间缩小 (-24.60毫秒) 的更大改善.
- 使用LBBAP,手术和光镜的时间显著缩短.
结论:
- 与CRT的BiVP相比,LBBAP与优异的临床结果有关,包括减少死亡率和住院病例.
- LBBAP提供了程序上的好处,并增强了心脏电气和功能参数.
- 建议进一步进行大规模随机试验,以验证这些发现.
相关概念视频
01:25Mitral Regurgitation III: Medical Management
686
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
686
01:18Dysrhythmias IV: Characteristics of Bradyarrhythmias
788
Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
788
01:25Dysrhythmias VI: Management of Dysrhythmias
597
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
597